Monash Medical Centre

Melbourne, Victoria 3168

1 studies enrolling now · 11 studies all time

What they study most

Bronchopulmonary Dysplasia, Chronic Hepatitis C, Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, HIV, Hepatitis C, Chronic, Hypertension, Intracerebral Hemorrhage, Lymphocytic Leukemia, Chronic, Ovarian Cancer, Pompe Disease (Late-onset), Preterm Birth, Stroke

Studies at this site

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia — Recruiting now
Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia — Completed
A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease — Completed
Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer — Status unconfirmed
The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? — Completed
OPTIMIST-A Trial: Minimally-invasive Surfactant Therapy in Preterm Infants 25-28 Weeks Gestation on CPAP — Status unconfirmed
Attenuation of D-dimer Using Vorapaxar to Target Inflammatory and Coagulation Endpoints — Completed
A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response — Completed
Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies — Completed
GS-5885, GS-9451 With Peginterferon Alfa 2a (PEG) and Ribavirin in Treatment-Naïve Subjects With Chronic Genotype 1 Hep C Virus Infection and IL28B CC Genotype — Stopped early
The Second Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial — Completed